Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1268, 2000-01, pp. : 15-16
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Eptifibatide keeps pace with abciximab in STEMI
Inpharma, Vol. 1, Iss. 1613, 2007-01 ,pp. :
Access to resources
Recommend
Continuation of Amiodarone Therapy Despite Type II Amiodarone-Induced Thyrotoxicosis
By Uzan Laurent
Drug Safety, Vol. 29, Iss. 3, 2006-01 ,pp. :
ICD therapy economically attractive in patients with stable HF
Inpharma, Vol. 1, Iss. 1559, 2006-01 ,pp. :
ICD therapy economically attractive in patients with stable HF
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 513, 2006-01 ,pp. :
Pharmaceutical & Diagnostic Innovation, Vol. 3, Iss. 11, 2005-01 ,pp. :